{"version":"1.0","type":"link","title":"Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.","author_name":"Karayama M 외","author_url":"https://prs-insight.online/author/Karayama%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/95772","thumbnail_width":1200,"thumbnail_height":630}